BIOHAVEN PHARMACEUTICAL HOLD's ticker is and the CUSIP is G11196106. A total of 1 filers reported holding BIOHAVEN PHARMACEUTICAL HOLD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $42,975,000 | -15.2% | 981,396 | -0.3% | 0.22% | -18.5% |
| Q1 2019 | $50,652,000 | +38.9% | 984,115 | -0.2% | 0.27% | +17.4% |
| Q4 2018 | $36,460,000 | -3.1% | 985,954 | -1.6% | 0.23% | +26.4% |
| Q3 2018 | $37,638,000 | -6.6% | 1,002,347 | -1.7% | 0.18% | -16.1% |
| Q2 2018 | $40,278,000 | +45.9% | 1,019,184 | -4.9% | 0.22% | +44.7% |
| Q1 2018 | $27,613,000 | -8.6% | 1,071,952 | -3.0% | 0.15% | -9.6% |
| Q4 2017 | $30,207,000 | -7.4% | 1,104,999 | +20.4% | 0.17% | -11.2% |
| Q3 2017 | $32,635,000 | +168.9% | 917,756 | +90.0% | 0.19% | +156.2% |
| Q2 2017 | $12,136,000 | – | 482,947 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EAGLE ASSET MANAGEMENT INC | 917,756 | $32,635,000 | 0.19% |